NM_000038.6:c.3982C>T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000038.6(APC):c.3982C>T(p.Gln1328*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q1328Q) has been classified as Likely benign.
Frequency
Consequence
NM_000038.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- classic or attenuated familial adenomatous polyposisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- desmoid tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- familial adenomatous polyposis 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- gastric adenocarcinoma and proximal polyposis of the stomachInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- APC-related attenuated familial adenomatous polyposisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Turcot syndrome with polyposisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cenani-Lenz syndactyly syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000038.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| APC | NM_000038.6 | MANE Select | c.3982C>T | p.Gln1328* | stop_gained | Exon 16 of 16 | NP_000029.2 | ||
| APC | NM_001407446.1 | c.4066C>T | p.Gln1356* | stop_gained | Exon 16 of 16 | NP_001394375.1 | |||
| APC | NM_001354896.2 | c.4036C>T | p.Gln1346* | stop_gained | Exon 17 of 17 | NP_001341825.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| APC | ENST00000257430.9 | TSL:5 MANE Select | c.3982C>T | p.Gln1328* | stop_gained | Exon 16 of 16 | ENSP00000257430.4 | ||
| APC | ENST00000508376.6 | TSL:1 | c.3982C>T | p.Gln1328* | stop_gained | Exon 17 of 17 | ENSP00000427089.2 | ||
| APC | ENST00000502371.3 | TSL:1 | n.*2180C>T | non_coding_transcript_exon | Exon 12 of 12 | ENSP00000484935.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:3
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation.
This sequence change creates a premature translational stop signal (p.Gln1328*) in the APC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 1516 amino acid(s) of the APC protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with familial adenomatous polyposis the literature (PMID: 8395941, 9101302, 14961559, 20685668, 26900293). ClinVar contains an entry for this variant (Variation ID: 92346). This variant is expected to disrupt the EB1 and HDLG binding sites, which mediate interactions with the cytoskeleton (PMID: 15311282, 17293347). While functional studies have not been performed to directly test the effect on APC protein function, this suggests that disruption of the C-terminal portion of the protein is functionally important. A different truncation (p.Tyr2645Lysfs*14) that lies downstream of this variant has been determined to be pathogenic (PMID: 9824584, 1316610, 27081525, 8381579, 22135120, internal data). This suggests that deletion of this region of the APC protein is causative of disease. For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:3
PVS1_Strong, PS2, PM2, PP4
Observed in multiple individuals with a personal and/or family history of adenomatous polyposis (PMID: 8395941, 9101302, 14961559); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 20685668, 26900293, 14961559, 22810696, 9101302, 25851626, 21901162, 30897307, 8395941, 18199528)
Gastric cancer;C0346629:Colorectal cancer;C1851124:Desmoid disease, hereditary;C2239176:Hepatocellular carcinoma;C2713442:Familial adenomatous polyposis 1;C4749917:Gastric adenocarcinoma and proximal polyposis of the stomach Pathogenic:1
Carcinoma of colon Pathogenic:1
The p.Gln1328X variant was identified in 6 of 192 proband chromosomes (frequency: 0.031) from Italian individuals or families with familial adenomatous polyposis (Paul 1993, De Rosa 2003, Gismondi 1997). The variant is listed in the dbSNP database (ID#: rs398123121) “With Pathogenic allele” however no frequency information was provided. The variant was not found in 1000 Genomes Project, NHLBI Exome Sequencing Project (Exome Variant Server), or the Exome Aggregation Consortium (ExAC) databases. The variant was identified 2x by Emory Genetics in the ClinVar database classified as a pathogenic variant. In Clinvitae the variant is classified 1x as pathogenic; and was identified 20x in COSMIC (15x as somatic mutations: 11x from tumour and 9x from an unknown source). In the “InSiGHT Colon Cancer Database”, the variant was identified 4x with no classification. In the UMD-APC database the variant was identified 6x as “causal”. The p.Gln1328X variant leads to a premature stop codon at position 1328, which is predicted to lead to a truncated or absent protein and loss of function. Loss of function variants of the APC gene are an established mechanism of disease in familial adenomatous polyposis and is the type of variant expected to cause the disorder. In summary, based on the above information, this variant meets our laboratory’s criteria to be classified as pathogenic.
APC-related disorder Pathogenic:1
The APC c.3982C>T variant is predicted to result in premature protein termination (p.Gln1328*). This variant has been reported in many individuals with familial adenomatous polyposis coli (Table 1, Pedigree 1193, Paul et al. 1993. PubMed ID: 8395941; Table 1, De Rosa et al. 2003. PubMed ID: 14961559; Table 1, Gismondi et al. 1997. PubMed ID: 9101302; Supplement, Lagarde et al. 2010. PubMed ID: 20685668; Table 1, de Oliveira et al. 2019. PubMed ID: 30897307). It has also been reported in individuals with colorectal cancer (Table 3, Chang et al. 2016. PubMed ID: 26900293). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. It is interpreted as pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/92346/). Nonsense variants in APC are expected to be pathogenic. Although this variant occurs in the terminal exon of APC, pathogenic truncating variants have been reported downstream of this variant (The Human Gene Mutation Database, https://www.hgmd.cf.ac.uk; ClinVar, https://www.ncbi.nlm.nih.gov/clinvar/). This variant is interpreted as pathogenic.
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.Q1328* pathogenic mutation (also known as c.3982C>T), located in coding exon 15 of the APC gene, results from a C to T substitution at nucleotide position 3982. This changes the amino acid from a glutamine to a stop codon within coding exon 15. This mutation (also designated Q1328X) has been reported in multiple individuals with a clinical diagnosis of familial adenomatous polyposis (FAP) (de Oliveira JC et al. Cancer Med, 2019 May;8:2114-2122; De Rosa M et al. Hum. Mutat. 2003 Jun;21:655-6; Gismondi V et al. Hum. Mutat. 1997;9:370-3; Lagarde A et al. J. Med. Genet. 2010 Oct;47:721-2; Paul P et al. Hum. Mol. Genet. 1993 Jul;2:925-31). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at